Company

Pfizer Inc

235 East 42nd Street
New York, NY 10017
United States






Pfizer Inc ( PFE)

Company > Health Care > Major Pharmaceuticals

     LAST CLOSE
            

      $ 33.82 ( -0.05)

     TRADING VOLUME
           

       35,356,936

     MARKET CAP
            

      $ 195.8B

     52-WEEK HIGH/LOW
           

      $ 28.49 - $42.56









     PREVIOUS    ESTIMATE

                2020           2021

          $ 0 | -

     P/E RATIO    P/E RATIO

             Trailing           Forward

           0 | -

     P/E RATIO    P/E RATIO

             Trailing           Forward

           - | -

     P/E RATIO    P/E RATIO

             Trailing           Forward

           - | -











PFE
S&P 500
     30-DAY CHANGE

          -9.22%
           2.56%

     90-DAY CHANGE

          -9.02%
           5.73%

180-DAY CHANGE

          -10.66%
           10.06%

52-WEEK CHANGE

          -3.3%
           29.14%









     DIVIDEND

      0.38

   DIVIDEND YIELD

1.12%

OUTSTANDING

5,780,474,578

50-DAY AVG VOLUME

31496704.74









     FISCAL YEAR END

     
      Dec 31

     Last Earning Date

     
      Feb 02, 2021

     EX-DIVIDEND DATE

     
      Jan 30, 2020

     EX-DIVIDEND DATE

     
      Jan 30, 2020

Ratios

      DEBT TO EQUITY
            

      0.52

      RETURN ON EQUITY
            

      17.49%

      BOOK VALUE
            

      $8.87

Stock Price Chart +

Quarterly Returns +

Year 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Q1 - -16.1 -2.7 -1.1 6.4 -7.2 12.7 5.7 16.1 5.8 -
Q2 - 0.2 1.5 4.5 -0.8 19.9 -2.8 -6.8 -2.1 2.8 -
Q3 - 12.2 -17.5 22.3 7.3 -3 -5.6 0.5 4.2 9.1 -
Q4 - 0.3 7.5 -0.6 1.3 -3.2 3.6 6.3 7.5 1.1 -

Monthly Returns +

Year Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2021 - - - - - - - - - - - -
2020 -4.72 -9.33 -2.83 17.52 -0.44 -14.38 17.68 -1.75 -2.92 -4.5 9.06 -3.7

Annual Returns +

Year 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
Returns43%-13%-22%18%-22%-11%15%-8%-17%9%
Year 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Returns0%29%20%26%5%7%4%16%25%-11%-5%-8%

Financial Statements

View More


Income Statement


Millions of US $ except per share data 2020-12-312019-12-312018-12-31
Revenue 419085175053647
Cost Of Goods Sold 86921021911248
Gross Profit 332164153142399

Balance Sheet


Millions of US $ except per share data 2020-12-312019-12-312018-12-31
Cash On Hand --18833
Notes And Loans Receivable ---
Inventory --7508

Cash Flow Statement


Millions of US $ except per share data 2020-12-312019-12-312018-12-31
Net Income/Loss --11188
Total Depreciation And Amortization - Cash Flow --6384
Other Non-Cash Items ---818


Income Statement


Millions of US $ except per share data 2020-12-312020-09-302020-06-30
Revenue 116841213111801
Cost Of Goods Sold 291925292281
Gross Profit 876596029520
Research And Development Expenses 335423602132
SG&A Expenses 375730163030
Other Operating Income Or Expenses ---
Operating Expenses 1107088078710
Operating Income 61433243091
Total Non-Operating Income/Expense -436-1148862
Pre-Tax Income 17821763953
Income Taxes -170-26519
Income After Taxes 34822023434
Other Income ---
Income From Continuous Operations 34822023434
Income From Discontinued Operations 257--
Net Income 59421943426
EBITDA -45864342
EBIT 61433243091
Basic Shares Outstanding 556255575554
Shares Outstanding 566256335619
Basic EPS 0.110.390.62
EPS - Earnings Per Share 0.10.390.61

Balance Sheet


Millions of US $ except per share data 2020-12-312020-09-302020-06-30
Cash On Hand -2191222794
Notes And Loans Receivable ---
Inventory -92958564
Other Current Assets -65192513
Total Current Assets -4773946424
Property, Plant, And Equipment -1440314113
Long-Term Investments -1900818720
Goodwill And Intangible Assets -9082991990
Other Long-Term Assets -43554327
Total Long-Term Assets -131244131510
Total Assets -178983177934
Total Current Liabilities -3415432723
Long Term Debt -4978550529
Other Non-Current Liabilities -1857118280
Total Long Term Liabilities -7933580648
Total Liabilities -113487113370
Common Stock Net -470470
Retained Earnings (Accumulated Deficit) -100284100203
Comprehensive Income --12676-13246
Other Share Holders Equity ---
Share Holder Equity -6549564564
Total Liabilities And Share Holders Equity -178983177934
Receivables -100129128
Pre-Paid Expenses ---

52-Week High/Low

Annual Earnings







Year Jun Mar Dec Sep Annual
2005 0.04 0.47 0.22 0.36 1.09
2006 0.56 0.33 0.46 1.31 2.66
2007 0.48 0.18 0.11 0.40 1.17
2008 0.41 0.41 0.34 0.04 1.2
2009 0.40 0.34 0.43 0.06 1.23
2010 0.25 0.31 0.11 0.35 1.02
2011 0.28 0.33 0.48 0.18 1.27
2012 0.24 0.43 0.43 0.84 1.94
2013 0.38 1.98 0.39 0.44 3.19
2014 0.36 0.45 0.42 0.19 1.42
2015 0.51 0.56 0.60 0.53 2.2
2016 0.67 0.64 0.61 0.47 2.39
2017 0.69 0.67 0.67 0.62 2.65
2018 0.77 0.81 0.78 0.64 3
2019 0.85 0.80 0.75 0.55 2.95
2020 - - - - -

Earnings Calendar


Quarter | Rep. Date
2020
| Jul 27
Quarter | Rep. Date
2019
Mar | Apr 30
Jun | Jul 29
Sep | Oct 29
Dec | Jan 28
Quarter | Rep. Date
2018
Mar | May 01
Jun | Jul 31
Sep | Oct 30
Dec | Jan 29
Quarter | Rep. Date
2017
Mar | May 02
Jun | Aug 01
Sep | Oct 31
Dec | Jan 30
Quarter | Rep. Date
2016
Mar | May 03
Jun | Aug 02
Sep | Nov 01
Dec | Jan 31

Dividend History


Year Mar Jun Sep Dec Annual
2020 0.38 0.38
2019 0.36 0.36 0.36 0.36 1.44
2018 0.34 0.34 0.34 0.34 1.36
2017 0.32 0.32 0.32 0.32 1.28
2016 0.3 0.3 0.3 0.3 1.2

Ex - Dividend Data & Date


Year Mar Jun Sep Dec Annual
2020 Jan 30 | 0.38 0.38
2019 Jan 31 | 0.36 May 09 | 0.36 Aug 01 | 0.36 Nov 07 | 0.36 1.44
2018 Feb 01 | 0.34 May 10 | 0.34 Aug 02 | 0.34 Nov 08 | 0.34 1.36
2017 Feb 01 | 0.32 May 10 | 0.32 Aug 02 | 0.32 Nov 09 | 0.32 1.28
2016 Feb 03 | 0.3 May 11 | 0.3 Aug 03 | 0.3 Nov 08 | 0.3 1.2